NKGen Biotech, Inc. Common Stock (NKGN)
$0.49 -$0.02 (-4.69%) 4:37 PM 12/10/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$15.50M -
Day's Range
$0.47 - $0.55 -
Volume
912,538 -
52 Week Low / High
$0.20 - $4.00 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
NKGN's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Company News
-
NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors — Jul 15th, 2024
NKGen Biotech SANTA ANA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer ...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$